Navigation Links
ImmBio Wins Funding from UK Government-Backed Biomedical Catalyst to Develop Multi-Strain Pneumococcal Vaccine
Date:3/12/2013

CAMBRIDGE, England, March 12, 2013 /PRNewswire/ --

ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.  This new grant follows the award of approximately £1 million ($1.5 million) at the end of 2012 by the Biomedical Catalyst, to support the development of ImmBio's novel meningococcal B vaccine, MenBioVax™.  The Biomedical Catalyst is a programme of public funding managed jointly by the UK's innovation agency, the Technology Strategy Board, and the Medical Research Council, which has to date awarded nearly £96 million to 115 projects to support the accelerated development of innovative solutions to healthcare challenges.

ImmBio's vaccine candidates are based on its proprietary ImmBioVax™ technology platform.  This uses novel cell-culture production processes to stress the target bacterial pathogen, mimicking the natural immune response to infection.  This innovative approach generates vaccines that incorporate multi-protein complexes, offering potential broad-based protection against a wide range of pathogen strains without the need for adjuvants or other immune stimulators.  

"ImmBio is delighted to receive funding from the UK's innovation agency and Medical Research Council to progress the development of our novel vaccines", said Graham Clarke , CEO of ImmBio.  "Successfully winning funding in both the first and second Biomedical Catalyst investment rounds represents a major vote of confidence in our ImmBioVax™ vaccine technology.  This most recent award recognises the need for effec
'/>"/>

SOURCE ImmBio
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Independa Closes Convertible Note Funding at $2.35 Million
2. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Igenica Closes $33 Million in Series C Funding
5. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
6. BONESUPPORT Closes Second Tranche of Funding
7. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
8. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
9. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
10. Prosum Kicks Off Crowd Funding for Cancer Research
11. Healthcare Expense Management Leader Patientco Receives $3.75M in funding led by BlueCross BlueShield Venture Partners and Sandbox Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 /PRNewswire-iReach/ -- This is a ... Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS ... information of Heparin sodium (CAS 9041-08-1) & calcium ... technology. The report then explores global and China,s ... calcium (CAS 37270-89-6) listing their product specification, capacity, ...
(Date:7/30/2014)... -- Hospira, Inc. (NYSE: HSP ), the ... technologies, today reported results for the second quarter ... quarter were $1.1 billion and adjusted* diluted earnings ... items as described later in this press release ... Accepted Accounting Principles (GAAP) basis, second-quarter 2014 diluted ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment Solutions, ... been awarded a Department of Defense (US Army) contract ... supply a mobile MRI diagnostic machine and technical support ... (WOSB) through the Small Business Administration (SBA), Medical Equipment ... field with the latest medical diagnostic equipment. The SBA ...
Breaking Medicine Technology:Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... 24, 2012 Marking a major milestone for ... a developer of oral drug delivery systems, announced today that ... Australian Patent Office. The patent covers an important part of ... of peptides. Oramed,s portfolio now consists of one issued patent ...
... Jan. 24, 2012  LoneStar Heart Inc., based here, today ... and Mark Maciejewski to the company,s board of directors. ... the board for LoneStar Heart; Frank Ahmann, the company,s ... executive officer of Vessix Vascular, Inc.; and Eric N. ...
Cached Medicine Technology:Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 3
(Date:7/30/2014)... 2014 Computer Resources of America, Inc. ... New York City, has been awarded the contract to ... of a large global bank. The bank is a ... Ramnarayan, CEO of CRA said, “Being awarded this contract ... further develop what has already been a successful and ...
(Date:7/30/2014)... July 30, 2014 According to the Critical ... is a comprehensive bodybuilding guide for men who want to ... up to 50 pounds in within a few months. Inside ... help keep their shoulders healthy and avoid the aches and ... Bench Program 2.0 uncovers to learners the reason why stretching ...
(Date:7/30/2014)... pMD, the leading innovator in ... Observation Result (ORU) interface to streamline cardiology test ... are using the ORU interface to automate charge ... for electrocardiograms, echocardiograms, and stress tests. , When ... cardiology system produces electronic data for each test ...
(Date:7/29/2014)... (PRWEB) July 30, 2014 VisitandCare.com ... centers have been added to the company’s exclusive network ... develop out of joint efforts — as top fertility ... initiative to offer affordable, state-of-the-art, and successful IVF treatments. ... begins with a comprehensive study by professionals at VisitandCare.com. ...
(Date:7/29/2014)... St. Petersburg, FL (PRWEB) July 30, 2014 Phytceramides ... explains how and why in her new book. , Today is ... Phytoceramides: Anti Aging At Its Best . The book is ... larger skin care book, but felt that Phytoceramides were ... sense to bring out this focused book now," says Kathy Heshelow, ...
Breaking Medicine News(10 mins):Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 2Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 3Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 2Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 3Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3
... drug-free way to treat agitation and depression among dementia patients, ... to know for sure, according to a review of recent ... during conversation helped ease agitation and restore appetite in dementia ... ,“Although the available reliable evidence supports the use of massage ...
... lead to the growth and spread of cancer. Controlling stress ... that stress results in the release of hormones that aggravate ... stimulates cancer cells to produce two compounds that can breakdown ... move easily into the bloodstream and travel to other parts ...
... a dramatic increase in the number of statin prescriptions in ... organised by the Royal College of Physicians of Edinburgh//. ... to offer a prescription than to persuade people to make ... a relatively low risk of heart disease were being put ...
... who inevitably convey the poisonous toxic meth chemicals to their ... novel Canadian Study. , ,Motherisk lab at the Hospital ... hair samples of adults and young children to gauge their ... is conveyed from the expectant mother to the unborn child. ...
... umbilical cord blood stem cells for the first time by ... drug testing. ,According to the scientists, this mini ... initial phase of generating segments that can be made use ... form. ,Scientists from Newcastle University worked in ...
... towards making healthcare more affordable, over 880 medicines including ... well as antibiotics would become cheaper. ,The new ... from Thursday with the government fixing the wholesale and ... of Chemicals and Fertiliser Ram Vilas Paswan said Tuesday ...
Cached Medicine News:Health News:Massage May Help Dementia Patients With Agitation 2Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Increased Warning over heart drugs 2Health News:Artificial Liver from Cord Blood Stem cells 2
... mirrors angled at 76°, 66° and 60°. ... well as central and peripheral fundus viewing and ... angled and spaced 120° apart to eliminate "gaps" ... of the lens also provides direct observation of ...
The Mid Field 30° lens has a bi-concave design to provide a wider field of view with a 30 degree offset image....
... 30° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... The Chalam 15° Prism ... pathologies and are recommended for ... etc.) and Rhegmatogenus retinal detachment. ... panretinal photocoagulation and other midperipheral ...
Medicine Products: